BCL2L11 and plasma cell myeloma: Mechanistically, venetoclax induces myeloma cell apoptosis by displacing proapoptotic BH3-only proteins (e.g., BIM and PUMA) from BCL2, leading to caspase-dependent cell death [10, 11].